Not Yet RecruitingNot Applicable

Can Artificial Intelligence Reduce Consumption of Standard High Volume Bowel Preparation Regimen Among Older Population, Without Compromising the Quality of Colonoscopy? An International Multi-centre Randomized Controlled Trial.

Hong Kong1,824 participantsStarted 2026-06-01

Plain-language summary

The goal of this study is to assess the clinical and cost-effectiveness of the AI bowel preparation evaluation system in reducing the consumption volume of the standard high-volume PEG regimen before colonoscopy among the older population. Researchers will compare bowel preparation adequacy and other colonoscopy quality matrices, and patient satisfaction between patients using the AI system and those using Standard Practice.

Who can participate

Age range65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * individual aged 65 years or above * undergoing colonoscopy for any indication * requiring a standard high-volume PEG regimen for bowel preparation * having a smartphone themselves or their caregivers (including ward nurses) having one will be recruited. Exclusion Criteria: * allergy to PEG, * suspected or diagnosed gastrointestinal obstruction or perforation, * suspected or diagnosed ileus * suspected or diagnosed gastric retention * suspected or diagnosed toxic colitis, toxic megacolon, * prior gastrointestinal surgery, and * unable to provide informed consent.

What they're measuring

Volume of PEG consumed

Timeframe: Baseline (before colonoscopy procedure)

Trial details

NCT IDNCT06904209

SponsorChinese University of Hong Kong

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2028-01-31

Contact for this trial

Felix Sia

852-26370428 felixsia@cuhk.edu.hk

View on ClinicalTrials.gov More Bowel Preparation Quality trials